Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YH12852 AME and Bioavailability Study in Healthy Males
NCT03381703Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2017
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of YH12852 in constipation, sponsored by Seoul National University Hospital. Primary endpoint: Total radioactivity. Started Mar 2017; status: completed.
02
Drugs
YH12852
03
Conditions
constipation
Beyond the preview
Go deeper on NCT03381703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03381703.